This website uses cookies. For more information please contact us or consult our privacy policy.

Your binder contains too many pages, the maximum is 40.

We are unable to add this page to your binder, please try again later.

This page has been added to your binder.

Former General Counsel of GlaxoSmithKline Joins Covington & Burling as Senior Of Counsel

March 6, 2002

March 6, 2002 - LONDON, U.K.- International law firm Covington & Burling is pleased to announce that James Beery, who recently retired as Senior Vice President and General Counsel of GlaxoSmithKline (GSK), one of the largest pharmaceutical companies in the world and the UK’s second largest company, will join the firm as Senior Of Counsel from 18 March.

Mr. Beery practiced law in London, New York and Tokyo for more than twenty years before joining SmithKline Beecham plc (SB) as General Counsel in 1994. Following SB’s £114bn merger with Glaxo Wellcome in 2000, he served as General Counsel of the combined company, with more than 500 legal staff and global responsibility. GSK operates in more than 100 countries.

Mr. Beery, a graduate of Harvard College and Stanford Law School and a former US Marine, says “Covington attracted me as a firm with a strong academic tradition and an unmatched life sciences practice.” During his break following retirement from GSK, Mr. Beery helped teach a course at Stanford Law School, and he intends to continue his relationship with Stanford while at Covington.

“As a general counsel, one gains a different perspective regarding both business and the practice of law. I hope that my industry experience will bring value to Covington and its clients.”

“Jim’s arrival is wonderful news for our clients and the firm. He would have been a great asset at any international firm, particularly one like ours which focuses on Life Sciences” says Stuart Stock, managing partner, “ We are delighted Jim chose Covington.”

“Jim is joining our London office as it enters a new stage of growth and development. Our expanding corporate and regulatory Life Sciences lawyers will enjoy calling on his industry expertise”. says Kurt Wimmer, Managing Partner of the London office.

For more information, please contact Kurt A. Wimmer, KWimmer@cov.com, 44.(0).20.7067.2010.

Share this article: